The Pharma Data

DECEMBER 23, 2020

23 2020 — From 2001 to 2016, out-of-pocket costs of evaluation and management (E/M) services and common diagnostic tests increased for neurology patients, according to a study published online Dec. WEDNESDAY, Dec. 23 in Neurology. Data were included for 3,724,342 patients. percent, respectively).

Research 52

Research 52

Broad Institute

AUGUST 11, 2023

In this role, she provides leadership and management for the large alliances, is the institutional official for the Broad’s animal facility and is the chief compliance officer for all human subject research. Donnelly received her B.A.

Bioethics 52

Bioethics Compliance Science Research 52

The Pharma Data

DECEMBER 24, 2020

24, 2020 — Rising out-of-pocket costs for neurological tests could lead many Americans to forgo them, researchers warn. The researchers also found an increase in patients who paid out-of-pocket costs for tests. For example, the percentage of patients who had out-of-pocket payments for MRIs rose from 24% in 2001 to 70% in 2016.

Research 52

Research 52

Drug Target Review

JULY 6, 2023

Programme : the leader programme ASP3082 entered the clinical trial phase last year, and multiple forum programmes are currently under investigation in the light research phase. According to Hayakawa, independently from this inhibitor research, Astellas’ scientists also started protein degrader research in the 2010s.

Targeted Protein Degradation 98

Targeted Protein Degradation Small Molecule Clinical Trials Science 98

Drug Target Review

NOVEMBER 1, 2023

Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. Acta Cryst. Acta Cryst. 2013) 56, 2059-2073.

Fragment Screening 96

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96

The Pharma Data

APRIL 10, 2021

Freire is President and Executive Director and member of the board of directors of the Foundation for the National Institutes of Health, a nonprofit organization committed to accelerating biomedical research and advancing breakthrough discoveries to fight critical diseases. a drug discovery and development company.

Government 52

Government Science Disease International 52

The Pharma Data

JANUARY 27, 2021

years) participating in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (1993 to 2001). The researchers found that aspirin use was not associated with the incidence of any studied cancer type. Loomans-Kropp, Ph.D., The analysis included 139,896 individuals (mean age, 66.4

Trials 52

Trials Research 52

Drug Target Review

JANUARY 31, 2024

During my fellowship at Cleveland Clinic, the opportunity to interact with clinicians helped me see the journey of a medicinal entity from the start – through all its research stages to the end, where it had immense impact on patient lives. It was the first time I had experienced the power of having allies and mentors.

Clinical Trials 97

Clinical Trials Production Science Research 97

The Pharma Data

NOVEMBER 30, 2020

A total of 2,350,330 singleton pregnancies were identified from 2001 to 2012, including 4,058 singleton pregnancies among psoriasis patients. The researchers found that the adjusted odds ratios (95 percent confidence intervals) were 1.57 (1.31 Yu-Heui Huang, M.D., to 1.89), 1.5 to 1.75), and 1.57 (1.36

Pharmaceuticals 52

Pharmaceuticals Research 52

The Pharma Data

NOVEMBER 23, 2020

Dietary information was collected at baseline (1993 to 2001) and follow-up (around 2010). Tong, Ph.D., from the University of Oxford in the United Kingdom, and colleagues conducted a prospective study to examine differences in fracture risks between vegetarians, vegans, and nonvegetarians.

Research 52

Research 52

The Pharma Data

OCTOBER 23, 2020

A pharmaceutical consultant at RMJ Consulting from 2008 to 2009, he found success as the vice president of global quality at Wyeth/FDAH from 2005 to 2008, the director of the Corporate Quality Center of Excellence of Abbott from 2001 to 2005, the director of corporate quality technology at Alcon Laboratories, Inc.,

Pharmaceuticals 52

Pharmaceuticals International Engineering Science 52

Drug Target Review

FEBRUARY 28, 2024

Preclinical research on γδ T cells has made great strides since the cells were first identified in the 1980s, with γδ T-cell therapies from several companies, including IN8bio, now in or nearing clinical trials for various cancers. from 2003 to 2006, covering the biotechnology and life-science tools sectors.

Therapies 105

Therapies Engineering Molecular Biology Science 105

The Pharma Data

OCTOBER 21, 2020

from the Karolinska Institutet in Stockholm, and colleagues performed a cohort study involving 3,016,307 Swedish women who participated in cervical screening during 2001 to 2012 to examine the risk for injuries during the diagnosis of cervical cancer and its precursor lesions. Qing Shen, Ph.D., and 3.04, respectively).

Hospitals 52

Hospitals Research 52

Advarra

JUNE 30, 2023

Background In 2001, Medicare released the national coverage determination (NCD) 310.1. Items and services not covered under the new mandatory Medicaid benefit include the investigational item itself, items/services not otherwise covered outside of the trial’s scope, and assessments solely performed for data collection or research purposes.

Clinical Trials 52

Clinical Trials Trials Laboratories Research 52

ACTO

OCTOBER 22, 2024

We’ve come a long way since Stanley Kubrick’s 2001: A Space Odyssey. And a leading technological research and consulting firm’s report from Q2 ’24 notes how a group of early AI adopters is “… distinctly outpacing the rest of organizations in life sciences … ” when it comes to AI deployments for drug discovery.

Science 52

Science Regulations FDA Compliance 52

The Pharma Data

SEPTEMBER 8, 2021

The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments. For example, in 2001 with anthrax and 2003 with SARS-CoV1, TIB Molbiol demonstrated their ability to develop PCR assays for the detection of new pathogens within days.

Virus 52

Virus Assay Development Disease Research 52

NIH Director's Blog: Drug Discovery

MAY 9, 2013

Caption: Researcher Zhaoxia Sun, at Yale, uses the zebrafish to study Polycystic Kidney Disease, which affects more than 600,000 Americans. 2001 Dec 1;15(23):3217-29. 2013 Apr 25;496(7446):443-4. [3] 3] vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain.

Disease 52

Disease Science International Regulations 52

PPD

MAY 11, 2023

To effectively implement vaccine clinical trials for special populations, it is critical for vaccine developers to partner with a contract research organization (CRO) that has demonstrated experience recruiting and retaining pediatric and elderly study participants — and managing the nuances these patients and their caregivers require.

Vaccine 52

Vaccine Clinical Trials Long-Term Care Facilities Trials 52

Drug Target Review

SEPTEMBER 26, 2023

Human derived induced pluripotent stem cells (hiPSCs) have revolutionised research and are increasingly used for toxicology screening and disease modelling. 27,28 Since the advent of hiPSC technology almost two decades ago enormous progress has been made in many areas of research. 2001 Sep;24(9):517–26. Cell Stem Cell.

Drugs 111

Drugs FDA Disease Animal Testing 111

The Pharma Data

JANUARY 10, 2021

SH ) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. At present, Chiauranib has globally applied for more than 40 patents of invention. About CHIPSCREEN BIOSCIENCES. Shenzhen Chipscreen Biosciences Co., Chipscreen Biosciences, Stock Symbol: 688321.

Clinical Trials 52

Clinical Trials Treatment Trials Small Molecule 52

The Pharma Data

NOVEMBER 6, 2020

She was employed by the university as a researcher from 1987 until 1988. Amy Dryman, DSc is a coauthor of research papers in psychiatric epidemiology that have been published and referenced in professional journals. Dr. Dryman continued her employment with the company as a manager from 2001 until 2004.

Science 40

Science Doctors Engineering Research 40

Alta Sciences

SEPTEMBER 13, 2023

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials pmjackson Wed, 09/13/2023 - 17:01 September is pain awareness month, and the importance of pain management and continued research into effective analgesics is integral to helping patients suffering from various pain conditions. WHY IS PAIN RESEARCH SO IMPORTANT?

Clinical Trials 52

Clinical Trials Treatment Trials Drug Development 52

Conversations in Drug Development Trends

MAY 23, 2024

Regulatory Harmonization of Clinical Trials in the EU The EU-CTR repealed the Clinical Trial Directive 2001/20/EC (CTD) and national implementing legislation in the EU Member States on 31 January 2022. This blog delves into the key aspects of the EU regulatory space and provides insights into navigating these changes effectively.

Trials 52

Trials Clinical Trials Therapies Treatment 52

The Pharma Data

NOVEMBER 23, 2020

The researchers also identified a notably higher risk for hip fractures among those who eat fish but no meat (pescatarians), and among vegetarians who swear off both meat and fish, but do consume dairy and/or eggs. All had enrolled in the EPIC-Oxford study between 1993 and 2001. MONDAY, Nov. “[Hip fracture] risk in vegans was 2.3

Production 52

Production Research 52

FDA Law Blog: Biosimilars

MAY 23, 2023

Part 117, and the Food Allergy Safety, Treatment, Education and Research Act (2021). the product label declares “tree nut” or “fish” but fails to declare the type of tree nut or species of fish in either the ingredient list or in a separate “Contains” statement).

FDA 45

FDA Compliance Regulations Production 45

The Pharma Data

DECEMBER 15, 2020

SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. Such cooperation will rapidly expand the coverage of the drug product after its launch, providing professional pharmaceutical services to doctors and patients, and benefit more patients.”

Pharmaceuticals 40

Pharmaceuticals Clinical Trials Small Molecule Disease 40

Drug Target Review

SEPTEMBER 10, 2024

This approach also requires an early identification of molecular liabilities and rheological properties, generally using research-grade material supply, in conjunction with in-silico modelling to de-risk drug formulation.

Drug Development 64

Drug Development Clinical Supply Production FDA 64

Codon

MARCH 28, 2023

In 2009, the USC professor received millions from the Defense Advanced Research Projects Agency, or DARPA, to build a device that plugs into the brain and enhances memory recall. That percentage might seem small, but it’s certainly much larger than the fraction of scientists, or even biomedical researchers, who work in this field.

Engineering 52

Engineering Research Science FDA Approval 52

Agency IQ

APRIL 12, 2024

MEP statements during a debate ahead of the vote highlighted alignment on provisions such as regulatory data protection and incentives for antimicrobial research. Directive 2001/83/EC and Regulation (EC) No 726/2004. providing an “attractive and innovation-friendly environment for research, development, and production of medicines;” 4.

Pharmaceuticals 40

Pharmaceuticals Regulations Packaging Marketing 40

The Pharma Data

DECEMBER 20, 2020

It is a large-scale Chinese pharmaceutical company that integrates research, production and distribution. Shanghai Haini) was founded in 2001. About YRPG Yangtze River Pharmaceutical Group (YRPG) was founded in 1971, which is headquartered in Taizhou, China. For more information, please visit our website, www.yangzijiang.com.

Licensing 40

Licensing Licensing Pharmaceuticals Pharmaceutical Companies 40

Agency IQ

NOVEMBER 20, 2023

See also Article 11 of Directive 2001/83/EC.) The Package Leaflet (PL, also sometimes called Package Information Leaflet or PIL) is included in medicine packaging and contains information for end-users, usually patients (see also Article 59 of Directive 2001/83/EC). The package leaflet will remain in paper form (at least for now).

Production 40

Production Packaging Hospitals Regulations 40

The Pharma Data

OCTOBER 18, 2020

Founded in 2001, ReWalk has headquarters in the United States, Israel and Germany. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. ReWalk® is a registered trademark of ReWalk Robotics Ltd.

Production 40

Production Compliance Marketing Government 40

New Drug Approvals

JANUARY 13, 2023

6] Research demonstrates that forasartan is also significantly less potent than losartan. [6] a comprehensive resource for ‘omics’ research on drugs” Nucleic Acids Research. “DrugBank: a knowledgebase for drugs, drug actions and drug targets” Nucleic Acids Research. “DrugBank 3.0:

Pharmacokinetics 52

Pharmacokinetics Drugs Production Research 52

Agency IQ

AUGUST 16, 2024

The road to research on psychedelic products is paved with obstacles. This means that research programs are subject to additional oversight from U.S. FDA released a draft guidance in June 2023 attempting to address many of these unique aspects of clinical research on psychedelic substances.

FDA 40

FDA Trials Therapies Regulations 40

Agency IQ

SEPTEMBER 29, 2023

GDPR) and “is without prejudice” to the laws on protection of intellectual property (2001/29/EC, 2004/48/EC and (EU) 2019/790). The public bodies can share data with research organizations conducting the studies according to the data request as well as with national statistical institutes and Eurostat that produce official statistics.

Regulations 40

Regulations Government Production International 40

The Pharma Data

OCTOBER 19, 2020

Intellia has received approval to launch their Phase I trial of NTLA-2001 in hereditary ATTR. Their NTLA-2001 candidate uses their proprietary non-viral lipid nanoparticle platform, which will deliver this CRISPR/Cas9-based therapy. who was part of the research duo that first developed CRISPR into a genome editing tool.

Therapies 52

Therapies Pharmacokinetics Trials Clinical Trials 52

Codon

FEBRUARY 20, 2024

More than two decades ago, though, some researchers in Tsukuba, Japan figured out a way to get around this problem and watch ATP synthase as it spins. The ATP synthase “bead” experiment was part of a 2001 study published in the journal Nature. In 2008, researchers at UC Berkeley devised an ingenious solution.

RNA 98

RNA DNA Engineering Cell Biology 98